IGF-1 LR3 1mg
IGF-1 LR3 is a modified research peptide studied in preclinical and in-vitro models involving growth-factor signaling, cellular proliferation, and metabolic pathway activity. Its extended molecular structure is also examined in comparative studies with standard IGF-1.
Research Studies
- Investigation of IGF-1 receptor signaling pathways
- Study of cellular proliferation and differentiation models
- Comparison of molecular activity duration with standard IGF-1
- Exploration of age-associated and muscle-tissue research mechanisms
For laboratory research only.
Wholesale access
Apply for Wholesale AccessPricing is quoted per order under our at-will wholesale model — based on the products and volumes you need. Apply for partner access to request a quote.
IGF-1 LR3 is a synthetic analog of insulin-like growth factor 1 supplied for controlled laboratory research. Preclinical and in-vitro literature has examined its interaction with growth-factor receptors, cellular signaling pathways, metabolic activity, and comparative molecular persistence.
Key Research Areas
- IGF-1 receptor interaction and signaling
- Cellular proliferation and differentiation
- Protein-synthesis pathway activity in laboratory models
- Comparative molecular persistence
- Age-associated and muscle-tissue research models
Research Context
IGF-1 LR3 remains an investigational research material. References to muscle tissue, cellular recovery, aging, or muscle-wasting models describe areas examined in laboratory literature and do not indicate medical, therapeutic, performance, or human-use outcomes.
For laboratory and in-vitro research only. Educational reference only.
| Goal | |
|---|---|
| Strength | 1mg |
| Count/Size | 5mL Vial |
